Inovio Pharmaceuticals Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| 251.1 | 173.6 | 156.4 | 136.1 | 157.0 | 105.4 | 152.9 | 114.1 | 168.9 | 153.5 | 136.2 | 457.0 | 409.0 | 1,200.2 | 4,241.2 | 18,418.4 | 11,503.2 | 2,382.9 | 3,499.5 | 3,619.9 | 2,788.5 | 7,109.9 | 5,901.4 | 2,270.1 | 463.4 | 40.0 | 20.8 | 12.4 | 122.7 | 167.7 | 451.5 | 372.2 | 802.4 | 224.5 | 153.5 | 425.9 | 658.1 | – | – | – | |
| 56.1 | 49.8 | 55.6 | 57.2 | 40.6 | 31.3 | 45.1 | 38.3 | 59.9 | 53.8 | 55.6 | 63.7 | 76.9 | 1,436.7 | 60.0 | 271.0 | 74.9 | 38.3 | 38.8 | 46.0 | 40.1 | 31.6 | 26.6 | 16.1 | 19.1 | 1.8 | 1.1 | 0.7 | 0.8 | 1.2 | 3.4 | 2.3 | 2.2 | 0.7 | 0.8 | 2.7 | – | 4.9 | 19.4 | 20.5 | |
| 250.7 | 173.6 | 155.9 | 135.8 | 156.6 | 105.4 | 152.0 | 114.1 | 168.4 | – | 137.5 | 463.0 | 418.5 | 1,214.0 | 4,219.1 | 18,413.4 | 11,445.0 | 2,351.9 | 3,489.1 | 3,613.4 | 2,780.7 | 7,079.7 | 5,876.4 | 2,259.8 | 463.2 | 37.4 | 19.9 | 8.9 | 122.4 | 173.5 | 427.2 | 318.0 | 707.7 | -66.3 | 21.6 | 306.9 | 472.5 | – | – | – | |
| -0.7% | -1.1% | -1.1% | -1.0% | -1.1% | -1.7% | -1.4% | -1.6% | -1.2% | -1.6% | -2.2% | -2.9% | -4.0% | -2.0% | -0.8% | -0.2% | -0.6% | -1.0% | -0.9% | -1.1% | -1.3% | -1.7% | -2.4% | -4.1% | -4.3% | -52.4% | -90.7% | -145.7% | -128.8% | -89.2% | -35.9% | -51.1% | -102.8% | -330.3% | -367.3% | -195.5% | -74.2% | -75.8% | -71.1% | -90.0% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| -145.2% | -150.8% | -152.6% | -91.6% | -133.3% | -133.5% | -195.5% | -159.8% | -154.4% | -212.5% | -199.1% | -1,173.2% | -1,358.2% | -1,994.3% | -2,265.7% | -2,148.2% | -1,913.2% | -556.8% | -654.1% | -307.1% | -303.6% | 22.3% | 13.9% | 34.8% | 87.4% | 86.9% | 75.4% | 74.0% | -192.8% | -59.5% | -30.4% | -198.0% | -1,143.5% | -1,337.4% | -737.3% | -1,152.3% | -1,143.4% | – | – | – | |
| -208.6% | -215.5% | -219.8% | -143.0% | -198.2% | -198.1% | -283.0% | -240.6% | -237.9% | -308.7% | -282.8% | -1,511.3% | -1,739.3% | -2,702.1% | -4,131.6% | -4,115.1% | -5,931.6% | -1,674.2% | -2,345.5% | -3,117.7% | -3,453.7% | -16,972.3% | -19,990.9% | -16,144.1% | -2,889.2% | -2,607.4% | -2,356.0% | -1,795.2% | -20,197.6% | -17,300.3% | -18,334.8% | -21,564.0% | -58,709.7% | -51,616.9% | -37,430.2% | -52,568.6% | -49,202.9% | – | – | – | |
| -199.6% | -208.5% | -235.9% | -153.5% | -221.5% | -208.9% | -292.1% | -253.0% | -232.6% | -318.1% | -295.2% | -1,560.9% | -1,809.9% | -2,902.8% | -4,701.7% | -8,099.7% | -8,517.7% | -2,245.4% | -2,916.7% | -2,193.4% | -3,392.3% | -17,109.9% | -20,485.9% | -16,775.8% | -3,027.3% | -2,726.7% | -2,371.7% | -1,750.9% | -19,270.7% | -16,239.9% | -17,423.4% | -20,552.3% | -55,491.1% | -49,254.3% | -34,079.6% | -48,131.4% | -59,281.7% | – | – | – | |
| -180.3% | -188.0% | -175.6% | -138.6% | -175.6% | -174.1% | -213.4% | -184.3% | -198.1% | -248.1% | -299.0% | -1,332.7% | -1,619.7% | -2,403.7% | -3,499.7% | -3,447.9% | -6,690.3% | -2,422.0% | -3,206.5% | -4,000.6% | -3,538.6% | -12,223.6% | -13,960.3% | -9,285.5% | -1,978.9% | -2,096.9% | -1,889.0% | -1,802.1% | -15,797.6% | -14,947.6% | -16,204.8% | -19,011.7% | -82,476.2% | -74,154.7% | -56,381.0% | -83,249.6% | -48,855.2% | – | – | – | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -44.6% | -59.8% | -83.9% | -64.5% | -57.4% | -61.9% | -86.3% | -85.0% | -82.5% | -111.5% | -120.4% | -217.4% | -340.3% | -3,474.7% | -66.6% | -119.2% | -55.5% | -36.1% | -32.4% | -27.9% | -48.7% | -76.0% | -92.5% | -119.2% | -124.6% | -125.8% | -121.2% | -99.4% | -119.1% | -115.1% | -132.3% | -125.7% | -153.5% | -156.6% | -188.2% | -307.6% | – | -352.5% | -1,399.7% | -1,542.6% | |
| -33.6% | -42.5% | -57.9% | -50.1% | -45.6% | -47.1% | -56.1% | -63.5% | -60.8% | -74.0% | -49.1% | -70.6% | -75.7% | -82.9% | -36.2% | -50.1% | -41.1% | -30.8% | -28.7% | -23.9% | -41.3% | -61.2% | -73.7% | -77.2% | -84.8% | -80.3% | -90.6% | -72.3% | -85.2% | -79.0% | -96.8% | -90.9% | -105.4% | -94.7% | -110.5% | -128.6% | -155.8% | -114.3% | -170.6% | -136.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -16 | 1.4 | -16 | -16 | -15 | 1.4 | -28 | -0.9 | -19 | – | 42 | 45 | 61 | 57 | -58 | -14 | -123 | -230 | -67 | -42 | -51 | -54 | -40 | -22 | -2.9 | -27 | -9.3 | -34 | -0.2 | 4.9 | -17 | -32 | -19 | -63 | -37 | -22 | -34 | -41 | -23 | -29 | |
| 75.5% | 71.0% | 69.0% | 77.7% | 79.5% | 76.0% | 65.1% | 74.8% | 73.6% | 66.3% | 40.8% | 32.5% | 22.2% | 2.4% | 54.4% | 42.0% | 74.0% | 85.4% | 88.8% | 85.9% | 84.7% | 80.6% | 79.7% | 64.8% | 68.0% | 63.8% | 74.7% | 72.7% | 71.5% | 68.6% | 73.1% | 72.3% | 68.7% | 60.5% | 58.7% | 41.8% | -11.1% | 32.4% | 12.2% | 8.9% | |
| 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 | – | 0.8 | 1.2 | 2.3 | 23.0 | 0.5 | 1.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | – | 0.1 | 0.5 | 0.7 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.89 | -0.99 | -1.19 | -1.06 | -1.07 | -0.98 | -1.08 | -1.04 | -0.93 | -0.99 | -0.96 | -1.19 | -1.12 | -0.96 | -0.98 | -1.42 | -1.03 | -1.01 | -0.93 | -0.68 | -1.05 | -1.44 | -1.50 | -1.51 | -1.33 | -13.08 | -11.21 | -7.65 | -7.35 | -5.93 | -5.36 | -4.47 | -4.01 | -3.95 | -3.55 | -2.26 | -2.07 | -1.23 | -1.23 | -0.83 | |
| 0.44 | 0.48 | 0.51 | 0.69 | 0.48 | 0.47 | 0.37 | 0.41 | 0.40 | 0.31 | 0.33 | 0.08 | 0.06 | 0.03 | 0.02 | 0.02 | 0.01 | 0.04 | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.04 | 0.48 | 0.47 | 0.44 | 0.04 | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | – | |
| 1.99 | 1.66 | 1.42 | 1.64 | 1.86 | 1.57 | 1.25 | 1.22 | 1.12 | 0.89 | 0.80 | 0.55 | 0.33 | 0.03 | 1.48 | 1.20 | 1.86 | 2.79 | 2.87 | 2.43 | 2.16 | 1.90 | 1.62 | 1.27 | 1.07 | 10.40 | 9.25 | 7.69 | 6.17 | 5.15 | 4.05 | 3.56 | 2.61 | 2.52 | 1.89 | 0.73 | -0.15 | 0.35 | 0.09 | 0.05 | |
| -0.80 | -0.90 | -0.89 | -0.95 | -0.85 | -0.81 | -0.79 | -0.76 | -0.79 | -0.78 | -0.97 | -1.01 | -1.00 | -0.79 | -0.73 | -0.61 | -0.81 | -1.09 | -1.02 | -1.23 | -1.10 | -1.03 | -1.02 | -0.83 | -0.87 | -10.06 | -8.93 | -7.87 | -6.03 | -5.46 | -4.99 | -4.14 | -5.96 | -5.95 | -5.88 | -3.91 | -1.71 | -1.29 | -1.21 | -0.99 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.